Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Ms Schoen said she believed it was unlikely that the court would overturn Roe v Wade....
...For more day-to-day election coverage follow us on Twitter at @Courtney_FT and @DimiSevastopulo....
...–Neil Munshi Follow us all on Twitter: @neiLmunshi, @barneyjopson, @Dimi and @Courtney_FT Click here for full FT coverage of the 2016 race....
...Follow us all on Twitter: @neiLmunshi, @barneyjopson, @Courtney_FT and @Dimi Click here for full FT coverage of the 2016 race. On the trail Why don’t Americans trust Clinton?...
...Courtney Weaver, US Political Correspondent Click here for full FT coverage of the 2016 race....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...Tucked away in a corner of Sheremetyevo Airport’s Terminal E, just to the right of Burger King, is an unassuming metal door which leads to the V-Express capsule hotel....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...In February, Pfizer announced plans to cut $3bn from its $9bn research budget, while last year GlaxoSmithKline reduced the proportion of sales it invests in R&D for prescription medicines....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Pfizer is to fund the project and hold the rights to worldwide exclusive milestone and royalty-bearing licences. After rising in early trading, Pfizer shares finished 0.3 per cent lower at $18.55....
...Athersys shares more than doubled to $2.40 while Pfizer, the world’s largest drugmaker, was up 1.7 per cent to $18.61....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition